CSTR Grand Rounds: May 2021 First-in-Class Phase 1/2 Clinical Trial Targeting Nitric Oxide in Treatment of Chemoresistant Triple-Negative Breast Cancer Patients (LIVE)
Ended May 31, 2021
1 credit
Sorry! The enrollment period is currently closed. Please check back soon.
Full course description
ACCREDITATION
Texas A&M University College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
DESIGNATION
Texas A&M University College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.FACULTY DISCLOSURE
Andrew Chung, MD/PhD Candidate, speaker for this educational activity has no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Louis Hinkle, MD/PhD Candidate, speaker for this educational activity has no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
PLANNERS DISCLOSURES
None of the planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.